Back
Bolt Biotherapeutics Quote, Financials, Valuation and Earnings
Sponsored
BOLT
Sponsored
NOW is the time to get in on this trillion-dollar megatrend
Get it here.
Sell
31
BOLT
Bolt Biotherapeutics
Last Price:
1.10
Seasonality Move:
-8.97%
7 Day Trial
ALL ACCESS PASS
$
7
I love this overnight trade happening Thursday
Access my free presentation on these overnight trades right hereBolt Biotherapeutics Price Quote
$1.10
Bolt Biotherapeutics Key Stats
Sell
31
Bolt Biotherapeutics (BOLT)
is a Sell
Day range:
$1.08 - $1.13
52-week range:
$0.84 - $2.03
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
5.28
P/B ratio:
0.37%
Volume:
90.7K
Avg. volume:
116.4K
1-year change:
-29.49%
Market cap:
$41.9M
Revenue:
$7.9M
EPS:
$-1.83
How Much Does Bolt Biotherapeutics Make?
-
How Much Are Bolt Biotherapeutics's Sales Annually?
BOLT Revenues are $7.9M -
How Much Profit Does Bolt Biotherapeutics's Make A Year?
BOLT net income is -$69.2M
Is Bolt Biotherapeutics Growing As A Company?
-
What Is Bolt Biotherapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.48% -
What Is Bolt Biotherapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Bolt Biotherapeutics Stock Price Performance
-
Did Bolt Biotherapeutics Stock Go Up Last Month?
Bolt Biotherapeutics share price went down by -26.67% last month -
Did BOLT's Share Price Rise Over The Last Year?
BOLT share price fell by -29.49% over the past 1 year
What Is Bolt Biotherapeutics 52-Week High & Low?
-
What Is Bolt Biotherapeutics’s 52-Week High Share Price?
Bolt Biotherapeutics has traded as high as $2.03 over the past 52 weeks -
What Is Bolt Biotherapeutics’s 52-Week Low Share Price?
Bolt Biotherapeutics has traded as low as $0.84 over the past 52 weeks
Bolt Biotherapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Bolt Biotherapeutics?
-
How Much Debt Does Bolt Biotherapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Bolt Biotherapeutics Have?
Cash and short term investments quarterly total is $102.2M -
What Is Bolt Biotherapeutics’s Book Value Per Share?
Book value per share is 2.96
Is Bolt Biotherapeutics Cash Flow Positive?
-
What Is BOLT Cash Flow From Operations?
Cash flow from operations (TTM) is -$69.5M -
What Is Bolt Biotherapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $253K -
What Is Bolt Biotherapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $71M
Bolt Biotherapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
BOLT return on invested capital is -48.57% -
What Is Bolt Biotherapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -36.05% -
What Is BOLT Return On Equity?
ROE is a measure of profitability and is -48.57%
Bolt Biotherapeutics Earnings Date & Stock Price
-
What Is Bolt Biotherapeutics's Stock Price Today?
A single share of BOLT can be purchased today for 1.10 -
What Is Bolt Biotherapeutics’s Stock Symbol?
Bolt Biotherapeutics trades on the nasdaq under the ticker symbol: BOLT -
When Is Bolt Biotherapeutics’s Next Earnings Date?
The next quarterly earnings date for Bolt Biotherapeutics is scheduled on May 10, 2024 -
When Is BOLT's next ex-dividend date?
Bolt Biotherapeutics's next ex-dividend date is August 29, 2014 -
How To Buy Bolt Biotherapeutics Stock?
You can buy Bolt Biotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Bolt Biotherapeutics Competitors
-
Who Are Bolt Biotherapeutics's Competitors?
Below is a list of companies who compete with Bolt Biotherapeutics or are related in some way:
Bolt Biotherapeutics Dividend Yield
Data Unavailable
Bolt Biotherapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 6.93% |
Revenue: | 48.05% | 16.64% |
Analyst Recommendations
Buy Recommendations: | 3 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 0 |
Price Target: | 4.45 |
Upside from Last Price: | 304.55% |